Kalaris Therapeutics Inc
KLRS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$59 | -$15 | -$15 | -$172 |
| Dep. & Amort. | $0 | $0 | $0 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$25 | -$1 | $3 | $19 |
| Other Non-Cash | $16 | $2 | $2 | $45 |
| Operating Cash Flow | -$68 | -$14 | -$10 | -$106 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$77 |
| Inv. Sales/Matur. | $95 | $0 | $0 | $263 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $95 | $0 | $0 | $186 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $6 | $4 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $8 | $8 | $0 |
| Financing Cash Flow | $0 | $14 | $13 | $0 |
| Forex Effect | $1 | $0 | $0 | -$1 |
| Net Chg. in Cash | $28 | $0 | $3 | $79 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $90 | $3 | $0 | $123 |
| End Cash | $118 | $3 | $3 | $202 |
| Free Cash Flow | -$68 | -$14 | -$10 | -$106 |